FIELD: medicine. SUBSTANCE: this tabletted composition includes 9-deoxy-11-deoxy-9,11-[amino[2-(2-methoxyethoxy)- ethylidene]-oxy]-(9S,16R)-erythromycin in the form of polymorphous modification. EFFECT: higher effectiveness. 2 cl
Title |
Year |
Author |
Number |
PROCESS FOR PREPARING CRYSTALLINE 9-DEOXO- 11-DEOXY -9,11-1 (IMINO[2- (2-METHOXYETHOXY) ETHYLIDENE) OXY-1) ERYTHROMYCIN |
1992 |
- Dzhon Maknejl Makgill[Us]
|
RU2045534C1 |
ACETONE, 1-BUTANOL, 1-PROPANOL OR 2-PROPANOL SOLVATES OF DIRYTHROMYCIN, CRYSTALLINE ACETONE, 1-BUTANOL, 1-PROPANOL OR 2-PROPANOL SOLVATES OF DIRYTHROMYCIN, PURIFIED FORM II OF DIRYTHROMYCIN, METHOD OF PREPARING DIRYTHROMYCIN FORM II, METHOD OF ISOLATION OF DIRYTHROMYCIN FORM II, METHOD OF SOLVATE PREPARING |
1992 |
- Dzhejms Majkl Grin[Us]
- Kholli Mari Khehnkins[Us]
- Gregori Alan Stehfenson[Us]
- Dehvid Dehjl Virt[Us]
|
RU2070203C1 |
MACROLIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITION |
1992 |
- Dzhasvant Sajn Dzhidda[Us]
- Gerbert Ehndrju Kirst[Us]
- Dehvid Vejn Robertson[Us]
|
RU2086560C1 |
USE OF 2-PHENYL-3-AROYLBENZOTHIEPHENES, THEIR SALTS OR SOLVATES FOR INHIBITION OF OSSEOUS TISSUE LOSS, PHARMACEUTICAL COMPOSITION CONTAINING 2-PHENYL-3-AROYLBENZOTHIEPHENES AND THEIR SALTS OR SOLVATES |
1995 |
- Majkl Uil'Jam Drejper[Us]
|
RU2100024C1 |
CEPHALOSPORIN DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION |
1992 |
- Robert Dzhon Ternanski[Us]
|
RU2104280C1 |
5-{[3,5-BIS-(1,1-DIMETHYLETHYL)-4-HYDROXYPHENYL]- METHYL}-4-THIAZOLIDINONE SHOWING ANTIINFLAMMATORY AND ANTIARTHRITIS ACTIVITY |
1992 |
|
RU2014329C1 |
GLYCOPEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1991 |
- Ramakrishnan Nagarajan[Us]
- Amalija Apolinarija Shejbel[Us]
|
RU2053240C1 |
AGENT FOR INHIBITION OF NEUROTOXICITY CAUSED BY BETA-AMYLOID PEPTIDES |
1994 |
|
RU2128992C1 |
USE OF 2-PHENYL-3-AROYLBENZOTHIOPHENES FOR SERUM BLOOD CHOLESTEROL DECREASE, PHARMACEUTICAL COMPOSITION |
1995 |
|
RU2150275C1 |
METHOD OF SUPPRESSION OF SKIN AND VAGINA ATROPHY |
1994 |
- Dzhordzh Dzhozef Kallinan
|
RU2143897C1 |